![]() |
Volumn 98, Issue 18, 2001, Pages 10031-10033
|
Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MUTANT PROTEIN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
RAPAMYCIN;
RAPAMYCIN DERIVATIVE;
TEMSIROLIMUS;
UNCLASSIFIED DRUG;
APOPTOSIS;
CANCER RESEARCH;
CELL MUTANT;
CHRONIC MYELOID LEUKEMIA;
GENE AMPLIFICATION;
GENE MUTATION;
NOTE;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
TUMOR GROWTH;
TUMOR SUPPRESSOR GENE;
1-PHOSPHATIDYLINOSITOL 3-KINASE;
ANIMALS;
CELL CYCLE PROTEINS;
DROSOPHILA PROTEINS;
ENZYME INHIBITORS;
FOCAL ADHESION KINASE 2;
HUMANS;
MICE;
MICE, KNOCKOUT;
MUTATION;
NEOPLASMS, EXPERIMENTAL;
PHOSPHORIC MONOESTER HYDROLASES;
PROTEIN-SERINE-THREONINE KINASES;
PROTEIN-TYROSINE KINASES;
PTEN PHOSPHOHYDROLASE;
RECEPTOR PROTEIN-TYROSINE KINASES;
SIGNAL TRANSDUCTION;
SIROLIMUS;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 0035964367
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.191379498 Document Type: Note |
Times cited : (126)
|
References (33)
|